Hellman L - Search Results

1

Therapeutic vaccines against IgE-mediated allergies.

Hellman L. Hellman L. Expert Rev Vaccines. 2008 Mar;7(2):193-208. doi: 10.1586/14760584.7.2.193. Expert Rev Vaccines. 2008. PMID: 18324889 Free article. Review.

2

Generation of therapeutic antibody responses against IgE through vaccination.

Vernersson M, Ledin A, Johansson J, Hellman L. Vernersson M, et al. Among authors: hellman l. FASEB J. 2002 Jun;16(8):875-7. doi: 10.1096/fj.01-0879fje. Epub 2002 Apr 10. FASEB J. 2002. PMID: 11967231

3

Identification of adjuvants that enhance the therapeutic antibody response to host IgE.

Johansson J, Ledin A, Vernersson M, Lövgren-Bengtsson K, Hellman L. Johansson J, et al. Among authors: hellman l. Vaccine. 2004 Jul 29;22(21-22):2873-80. doi: 10.1016/j.vaccine.2003.12.029. Vaccine. 2004. PMID: 15246623

4

Generation of therapeutic antibody responses against IgE in dogs, an animal species with exceptionally high plasma IgE levels.

Ledin A, Bergvall K, Hillbertz NS, Hansson H, Andersson G, Hedhammar A, Hellman L. Ledin A, et al. Among authors: hellman l. Vaccine. 2006 Jan 9;24(1):66-74. doi: 10.1016/j.vaccine.2005.07.052. Epub 2005 Aug 10. Vaccine. 2006. PMID: 16169131

5

Regulation of IgE homeostasis, and the identification of potential targets for therapeutic intervention.

Hellman L. Hellman L. Biomed Pharmacother. 2007 Jan;61(1):34-49. doi: 10.1016/j.biopha.2006.10.001. Epub 2006 Nov 14. Biomed Pharmacother. 2007. PMID: 17145160 Review.

6

Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.

Johansson J, Hellman L. Johansson J, et al. Among authors: hellman l. Vaccine. 2007 Feb 19;25(9):1676-82. doi: 10.1016/j.vaccine.2006.10.055. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17150285

7

Is vaccination against IgE possible?

Hellman L. Hellman L. Adv Exp Med Biol. 1996;409:337-42. doi: 10.1007/978-1-4615-5855-2_47. Adv Exp Med Biol. 1996. PMID: 9095262 Review.

8

Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.

Ringvall M, Huijbers EJ, Ahooghalandari P, Alekseeva L, Andronova T, Olsson AK, Hellman L. Ringvall M, et al. Among authors: hellman l. Vaccine. 2009 Dec 10;28(1):48-52. doi: 10.1016/j.vaccine.2009.09.122. Epub 2009 Oct 25. Vaccine. 2009. PMID: 19835827

9

Vaccination against the extra domain-B of fibronectin as a novel tumor therapy.

Huijbers EJ, Ringvall M, Femel J, Kalamajski S, Lukinius A, Abrink M, Hellman L, Olsson AK. Huijbers EJ, et al. Among authors: hellman l. FASEB J. 2010 Nov;24(11):4535-44. doi: 10.1096/fj.10-163022. Epub 2010 Jul 15. FASEB J. 2010. PMID: 20634349

10

Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma.

Lei Y, Boinapally V, Zoltowska A, Adner M, Hellman L, Nilsson G. Lei Y, et al. Among authors: hellman l. PLoS One. 2015 Jul 27;10(7):e0133774. doi: 10.1371/journal.pone.0133774. eCollection 2015. PLoS One. 2015. PMID: 26214807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters